|
Abnormal prenylation of Ras isoforms in high glucose vascular pathology
Dr Amanda Mather, Renal Research Group, Kolling Institute, University of Sydney, Australia
|
|
The influence of TGFβ1 on Ras expression and prenylation in endothelial cells
Dr Amanda Mather, Renal Research Group, Kolling Institute, University of Sydney, Australia
|
|
PPAR alpha and gamma agonists attenuate diabetic kidney disease
Dr Anna Calkin, Baker Heart Research Institute, Australia
|
|
Developmental expression of ACE2 in the rodent kidney ; a role in hypertension?
Dr Chris Tikellis, Baker Heart Research Institute, Australia
|
|
Seliciclib reduces tubular epithelial cell proliferation in non-immune initiated focal segmental glomerulosclerosis
Ms Lena Succar, Centre for Transplant and Renal Research, Westmead Millennium Institute, The University of Sydney, Australia
|
|
Interleukin-18 Binding Protein Therapy is Protective in Adriamycin Nephropathy
Kate R Wyburn, Renal Department and The Collaborative Transplant Research Group, Royal Prince Alfred Hospital, University of Sydney, Australia
|
|
Blockade of p38 MAPK and TGF-beta1/Smad Signaling Pathways Rescues Bone Marrow-derived Peritubular Capillary Endothelial Cells in Adriamycin-induced Nephrosis
Dr Jinhua Li, Monash University, Australia
|
|
Tranilast ameliorates experimental mesangial proliferative glomerulonephritis
Yuan Zhang, Australia
Hirobumi Tokuyama, St Vincent's Hospital & University of Melbourne, Australia
Alison Cox, Australia
Richard Gilbert, Australia
Laura Di Rago, Australia
A/Prof Darren J Kelly, Australia
Dr David J Nikolic-Paterson, Department of Nephrology and Monash University Department of Medicine, Monash Medical Centre, Australia
|
|
Endogenous PAI-1 is Pathogenic in Experimental Diabetic Nephropathy
A/Prof A Richard Kitching, Monash University Department of Medicine, Australia
|
|
Renoprotective effects of the AT1 receptor blocker candesartan and the HMG-CoA reductase inhibitor rosuvastatin alone or in combination in diabetic apoE knockout mice
Dr Sara Giunti, Baker Heart Research Institute, Australia
Dr Anna Calkin, Baker Heart Research Institute, Australia
Dr Josephine Forbes, Baker Heart Research Institute, Australia
Dr Terri J Allen, Baker Heart Research Institute, Australia
A/Prof Merlin C Thomas, Baker Heart Research Institute, Australia
Prof Mark E Cooper, Baker Heart Research Institute, Australia
Dr Karin AM Jandeleit-Dahm, Baker Heart Research Institute, Australia
|
|
Distinct Mechanisms by which JNK1 and MKK3 Signalling Contribute to Streptozotocin-Induced Type 1 Diabetes
Dr David J Nikolic-Paterson, Department of Nephrology and Monash University Department of Medicine, Monash Medical Centre, Australia
|
|
Advanced Glycation End Products – Effect of PPAR gamma Agonists on Fibronectin Expression in a Model of Human Proximal Tubular Cells
Usha Panchapakesan, Kolling Institute of Medical Research, Royal North Shore Hospital, Australia
|
|
Interactions between Advanced Glycation End Products (AGEs) and their Receptors in Primary Renal Cells and their Role in the Progression of Diabetic Nephropathy
Brooke E Harcourt, Albert Einstein Centre for Diabetes Complications, Wynn Domain, Baker Heart Research Institute, Melbourne, Australia
|
|
Diabetes-induced advanced glycation initiates mitochondrial dysfunction
Melinda T Coughlan, Baker Heart Research Insitute, Australia
|
|
Transcriptional profile induced by high glucose in human endothelial cells
Dr Amanda Mather, Renal Research Group, Kolling Institute, University of Sydney, Australia
|
|
The role of stress activated protein kinase signalling in LPS-induced peritoneal membrane dysfunction
Dr Gregory H Tesch, Department of Nephrology and Monash University Department of Medicine, Monash Medical Centre., Australia
|
|
Do the Newer Dialysis Fluids Ameliorate Stress-Activated Protein Kinase Responses in Human Peritoneal Mesothelial Cells?
Dr Melinda M Tee, Monash Medical Centre and Monash University, Australia
|
|
Progressive Decline Of Renal Function In IgA Nephropathy Is Associated With Elevated Gene Expression Of PKC-ß
Ms Renae M Gow, University of Melbourne Department of Medicine, Australia
|
|
Polycystic kidney disease-related genes and renal repair
Elizabeth Verghese, Monash Immunology and Stem Cell laboratories, Monash University, Australia
|